Lexicon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. 

CEO
Michael Exton
CEOMichael Exton
Employees
103
Employees103
Headquarters
The Woodlands, Texas
HeadquartersThe Woodlands, Texas
Founded
1995
Founded1995
Employees
103
Employees103

LXRX Key Statistics

Market cap
261.49M
Market cap261.49M
Price-Earnings ratio
-1.40
Price-Earnings ratio-1.40
Dividend yield
Dividend yield
Average volume
4.23M
Average volume4.23M
High today
$0.75
High today$0.75
Low today
$0.655
Low today$0.655
Open price
$0.665
Open price$0.665
Volume
4.64M
Volume4.64M
52 Week high
$2.45
52 Week high$2.45
52 Week low
$0.2836
52 Week low$0.2836

LXRX News

Simply Wall St 5d
Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. After Shares Rise 31%

Lexicon Pharmaceuticals, Inc. ( ) shares have continued their recent momentum with a 31% gain in the last month alone. Still, the 30-day jump doesn't change the...

Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. After Shares Rise 31%

People also own

Based on the portfolios of people who own LXRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.